why choose us

First received: August 22, 2022

Clinical Trial: A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Primary Immunodeficiency Diseases (PID)

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Open-label, Non-controlled, Extension Study to Evaluate the Long-term Safety of TAK-771 in Japanese Patients With Primary Immunodeficiency Disease (PID)

Brief Summary: The main aim of the study is to check side effect from the study treatment with TAK-771 in long term.Participants can have taken part in the previous study TAK-771-3004 (NCT05150340).For those who can take part, the participants will receive injections of TAK-771 after the end of the previous study.The participants will be treated with TAK-771 for totally 3 years.There will be many clinic visits.The number of visits will depend on the infusion cycles of study drug.

Read more